Capsaicin (topical 0.025%)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Capsaicin (topical 0.025%), covering 2020-01-06 to 2020-01-06. Get the full timeline:
Most recent: Clinical Trial Update: Topical Use of 20% Beta Caryophyllene Alone And In Combination With 0.025% Capsaicin for Pain Caused by Osteoarthritis Of The Knee [Phase 2]